Evidence map›Paper›PMID 28903782›Full record

ArticleGenome biology2017

Natural genetic variation of the cardiac transcriptome in non-diseased donors and patients with dilated cardiomyopathy.

Matthias Heinig, Michiel E Adriaens, Sebastian Schafer, Hanneke W M van Deutekom, Elisabeth M Lodder, James S Ware, Valentin Schneider, Leanne E Felkin, Esther E Creemers, Benjamin Meder and 21 more

Open access · goldAbstract read
In one paragraph

Article in Genome biology, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 53 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
53citing papers in PubMed, 1 pooled it
4.5field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

53 citing papers in PubMed, 1 synthesis or guideline pooled it, 87 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Region- and Cell-type-Resolved Multiomic Atlas of the Heart.Molecular & cellular proteomics : MCP · 2025
    Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Three Modes of Viral Adaption by the Heart.bioRxiv : the preprint server for biology · 2024
    Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

31 authors at 13 institutions in 8 countries.

Matthias HeinigInstitute of Computational Biology, Helmholtz Zentrum München, München, Germany.ORCID 0000-0002-5612-1720
Michiel E AdriaensDepartment of Clinical and Experimental Cardiology, Heart Center, Academic Medical Center, University of Amsterdam, Meibergdreef 9, Amsterdam, 1105AZ, The Netherlands.
Sebastian SchaferNational Heart Research Institute Singapore, National Heart Centre Singapore, 168752, Singapore, Singapore.
Hanneke W M van DeutekomDepartment of Clinical and Experimental Cardiology, Heart Center, Academic Medical Center, University of Amsterdam, Meibergdreef 9, Amsterdam, 1105AZ, The Netherlands.
Elisabeth M LodderDepartment of Clinical and Experimental Cardiology, Heart Center, Academic Medical Center, University of Amsterdam, Meibergdreef 9, Amsterdam, 1105AZ, The Netherlands.
James S WareNational Heart and Lung Institute, Imperial College London, London, UK.
Valentin SchneiderCardiovascular and Metabolic Sciences, Max-Delbrück-Center for Molecular Medicine (MDC) in the Helmholtz Association, Robert-Rössle-Str. 10, 13125, Berlin, Germany.
Leanne E FelkinNational Heart and Lung Institute, Imperial College London, London, UK.
Esther E CreemersDepartment of Clinical and Experimental Cardiology, Heart Center, Academic Medical Center, University of Amsterdam, Meibergdreef 9, Amsterdam, 1105AZ, The Netherlands.
Benjamin MederInstitute for Cardiomyopathies Heidelberg & Department of Cardiology, Angiology and Pneumology, University Heidelberg, Heidelberg, Germany.
Hugo A KatusInstitute for Cardiomyopathies Heidelberg & Department of Cardiology, Angiology and Pneumology, University Heidelberg, Heidelberg, Germany.
Frank RühleInstitute of Human Genetics, Genetic Epidemiology, University of Münster, Münster, Germany.
Monika StollInstitute of Human Genetics, Genetic Epidemiology, University of Münster, Münster, Germany.
François CambienSorbonne Universités, UPMC Univ Paris 06, INSERM UMRS 1166, Team Genomics & Pathophysiology of Cardiovascular Diseases, F-75013, Paris, France.
Eric VillardSorbonne Universités, UPMC Univ Paris 06, INSERM UMRS 1166, Team Genomics & Pathophysiology of Cardiovascular Diseases, F-75013, Paris, France.
Philippe CharronICAN Institute for Cardiometabolism and Nutrition, F-75013, Paris, France.
Andras VarroDepartment of Pharmacology and Pharmacotherapy, Faculty of Medicine, University of Szeged, Szeged, Hungary.
Nanette H BishopricDepartment of Medicine, University of Miami School of Medicine, Miami, FL, USA.
Alfred L GeorgeDivision of Genetic Medicine, Department of Medicine, Vanderbilt University, Nashville, TN, USA.
Cristobal Dos RemediosSydney Heart Bank, Department of Anatomy, Bosch Institute, The University of Sydney, Sydney, Australia.
Aida Moreno-MoralProgram in Cardiovascular and Metabolic Disorders, Center for Computational Biology, DUKE-NUS Medical School, Singapore, 169857, Singapore.
Francesco PesceNational Heart and Lung Institute, Imperial College London, London, UK.
Anja BauerfeindCardiovascular and Metabolic Sciences, Max-Delbrück-Center for Molecular Medicine (MDC) in the Helmholtz Association, Robert-Rössle-Str. 10, 13125, Berlin, Germany.
Franz RüschendorfCardiovascular and Metabolic Sciences, Max-Delbrück-Center for Molecular Medicine (MDC) in the Helmholtz Association, Robert-Rössle-Str. 10, 13125, Berlin, Germany.
Carola RintischCardiovascular and Metabolic Sciences, Max-Delbrück-Center for Molecular Medicine (MDC) in the Helmholtz Association, Robert-Rössle-Str. 10, 13125, Berlin, Germany.
Enrico PetrettoProgram in Cardiovascular and Metabolic Disorders, Center for Computational Biology, DUKE-NUS Medical School, Singapore, 169857, Singapore.
Paul J BartonNational Heart and Lung Institute, Imperial College London, London, UK.
Stuart A CookNational Heart Research Institute Singapore, National Heart Centre Singapore, 168752, Singapore, Singapore.
Yigal M PintoDepartment of Clinical and Experimental Cardiology, Heart Center, Academic Medical Center, University of Amsterdam, Meibergdreef 9, Amsterdam, 1105AZ, The Netherlands.
Connie R BezzinaDepartment of Clinical and Experimental Cardiology, Heart Center, Academic Medical Center, University of Amsterdam, Meibergdreef 9, Amsterdam, 1105AZ, The Netherlands. c.r.bezzina@amc.uva.nl.
Norbert HubnerCardiovascular and Metabolic Sciences, Max-Delbrück-Center for Molecular Medicine (MDC) in the Helmholtz Association, Robert-Rössle-Str. 10, 13125, Berlin, Germany. nhuebner@mdc-berlin.de.
Amsterdam UMC Location University of Amsterdam · NLMax Delbrück Center · DEHarefield Hospital · GBInserm · FRDuke-NUS Medical School · SGHeidelberg University · DENational University of Singapore · SGUniversity of Münster · DEHelmholtz Zentrum München · DENorthwestern University · USThe University of Sydney · AUUniversity of Miami · USUniversity of Szeged · HU

Funding

Transcription Programming in Cardiac GrowthR01HL071094 · NHLBI · UNIVERSITY OF MIAMI SCHOOL OF MEDICINE · PI BISHOPRIC, NANETTE HAHR · 2003 to 2012
$3.4M
British Heart Foundation FS/11/25/28740British Heart Foundation SP/10/10/28431Medical Research Council MC_U120085815Medical Research Council MC_U120097112Medical Research Council MC_UP_1102/20NHLBI NIH HHS R01 HL071094Wellcome Trust
6 · The paper itself

Abstract

backgroundGenetic variation is an important determinant of RNA transcription and splicing, which in turn contributes to variation in human traits, including cardiovascular diseases.

resultsHere we report the first in-depth survey of heart transcriptome variation using RNA-sequencing in 97 patients with dilated cardiomyopathy and 108 non-diseased controls. We reveal extensive differences of gene expression and splicing between dilated cardiomyopathy patients and controls, affecting known as well as novel dilated cardiomyopathy genes. Moreover, we show a widespread effect of genetic variation on the regulation of transcription, isoform usage, and allele-specific expression. Systematic annotation of genome-wide association SNPs identifies 60 functional candidate genes for heart phenotypes, representing 20% of all published heart genome-wide association loci. Focusing on the dilated cardiomyopathy phenotype we found that eQTL variants are also enriched for dilated cardiomyopathy genome-wide association signals in two independent cohorts.

conclusionsRNA transcription, splicing, and allele-specific expression are each important determinants of the dilated cardiomyopathy phenotype and are controlled by genetic factors. Our results represent a powerful resource for the field of cardiovascular genetics.

Indexed as

Genetic VariationTranscriptomeAdultAllelesAlternative SplicingCardiomyopathy, DilatedFemaleGene Expression RegulationGenome-Wide Association StudyGenotypeHeart VentriclesHumansMaleMiddle AgedMyocardiumPolymorphism, Single NucleotideDilated cardiomyopathyeQTLGene expressionGeneticsHeart

Identifiers

PMID28903782
PMCPMC5598015
OpenAlexW2755253712

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.